Home › Patheon Expands Early Development Offerings and Capacity At U.K. Facility
 

Keywords :   


Patheon Expands Early Development Offerings and Capacity At U.K. Facility

2014-01-16 17:36:30| drugdiscoveryonline News Articles

Patheon's investment in early development capabilities in Europe means expanded capacity for handling highly potent compounds in the early pharmaceutical development phases at the Milton Park facility and then feeding into the later stage and commercialization capabilities at a site in Bourgoin, France.

Tags: development uk early capacity

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06XREAL bring Play Store apps to 3D space on XREAL AR glasses
26.06Qwilt reveals live streaming survey results
26.06Rockline Industries Wins WOW Innovation Award
26.06IMS Technologies Expands Calcinate Production Site
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
More »